BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee
BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee
复制标题
DOI：
10.1016/j.bbmt.2017.12.774
复制
发表时间：
2018-04-01
影响因子：
4.3
通讯作者：
McCarthy, Philip L.
中科院分区：
文献类型：
--
作者：
Holstein, Sarah A.;Avet-Loiseau, Herve;McCarthy, Philip L.
血液和骨髓移植临床试验网络骨髓瘤最小残留疾病和免疫谱组间研讨会于2016年12月1日在美国血液学会会议上召开，讨论骨髓瘤最小残留疾病评估和免疫谱的新兴数据和技术。特别强调的是制定策略，将这些技术纳入临床试验设计。本文回顾了文献，总结了研讨会上讨论的主题，并提供了将这些技术整合到未来临床试验设计中的建议。(C) 2017年美国血液和骨髓移植学会。
The Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 1, 2016 at the American Society of Hematology meeting to discuss the emerging data and technologies for minimal residual disease assessment and immune profiling in myeloma. Particular emphasis was placed on developing strategies to incorporate these techniques into clinical trial design. This document reviews the literature, summarizes the topics discussed in the workshop, and provides recommendations for integration of these techniques into future clinical trial design. (C) 2017 American Society for Blood and Marrow Transplantation.